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Abstract 
Introduction: South China has a proven role in the global epidemiology of previous influenza outbreaks due to its dual seasonal pattern. We 
present the virologic, genetic and clinical characterization of pandemic H1N1 influenza infection (pH1N1) in Shantou and Nanchang, cities 
in southern China, during the second wave of the 2009-2010 pandemic.  
Methodology: Nasopharyngeal swabs were collected from 165 individuals with influenza-like illness (ILI) who presented to the hospitals in 
Shantou and Nanchang. Laboratory diagnosis and characterization was performed by real-time PCR, virus isolation in embryonated chicken 
eggs, and sequencing.     
Results:  pH1N1 activity was sustained in three different temporal patterns throughout the study period. The overall positivity rate of pH1N1 
was 50% with major distribution among young adults between the ages of 13 and 30 years. High fever, cough, expectoration, chest pain, 
myalgia, nasal discharge and efficient viral replication were observed as major clinical markers whereas a substantial number of afebrile 
cases (17%) was also observed. Rate of hospitalization and disease severity (39%) and recovery (100%) were also high within the region. 
Furthermore, severe complications were likely to develop in young adults upon pH1N1 infection. Genetic characterization of the HA and NA 
genes of pH1N1 strains exhibited homogenous spread of pH1N1 strains with 99% identity with prototypic strains; however, minor unique 
mutations were also observed in the HA gene. 
Conclusion: The study illustrates the detailed characteristics of 2009 influenza pandemic in southern parts of China that might help to 
strategize preparedness for future pandemics and subsequent influenza seasons. 
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Introduction 
 In 2009, the novel strain influenza A (H1N1) 
virus that carried a unique combination of gene 
segments from four different lineages emerged and 
quickly attained pandemic status.  With a high attack 
rate similar to those of  contemporary strains, 
pandemic 2009 influenza H1N1 virus (pH1N1 
hereafter) penetrated globally but more specifically in 
school-aged children, young adults, and patients with 
underlying co-morbidities [1-3]. The clinical 
spectrum of the disease ranged from mild to severe 
illness with increased rate of hospitalization and case 
fatality.  Notably unlike previous pandemics, pH1N1 
sustained its infectivity ratio and severity of illness 
during multiple waves of the pandemic, claiming 
more than 15,000 mortalities and infecting 1.5 
million people in 208 countries (World Health 
Organization, 
http://www.who.int/csr/disease/swineflu/en/ date of 
access 12 December 2010). However, the actual 
numbers might be much higher due to the 
unavailability of data from patients with mild 
sickness and insufficient surveillance in certain areas 
of the world. Although the transmission of pH1N1 
has been demoted to the level of seasonal influenza, 
the continued circulation of the virus gives it the 
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potential to mutate. This situation might present more 
complex challenges to health-care providers and 
researchers alike as we move into next influenza 
seasons. Therefore, it is critical to understand the 
global dynamics of the 2009-2010 pandemic.  
Although valuable information has been generated, 
clinico-epidemiological data is still emerging from 
different parts of the world.  
China declared its first few cases of pH1N1 
infection in May 2009 [4] and these were followed by 
a rapid transmission of infection in the community. 
According to the Chinese Ministry of Health, 
approximately 197,000 suspected cases of influenza-
like illness (ILI) were observed during the 2009-2010 
flu season (http://www.cnic.org.cn/eng) with a 
considerably high proportion of hospitalizations, ICU 
admissions, and deaths [5-8]. However, available 
data, mostly based on case reports and retrospective 
analyses, portray the clinical picture of cases as 
situated in urban areas of the country, especially in 
Beijing and Shanghai, which are more likely to have 
been affected by international travel and do not 
represent a large portion of the Chinese population 
[4,6-12].  Southern parts of mainland China, where 
Shantou and Nanchang are located, represent smaller 
urban centers more than the typical Chinese 
demographics. Interestingly, due to unique seasonal 
variation, influenza activity is sustained in the region 
throughout the year with a sharp peak in summer and 
a moderate peak in winter season [13], and thus the 
area exhibits the gross impact of the influenza 
epidemiology in the country. Therefore, it merits 
knowing the epidemiological picture of influenza 
activity in this region during the 2009 pandemic, 
which is largely missing in the current body of 
literature.  
In this study we summarize the clinical and 
virological profile of influenza activity in southern 
parts of mainland China during the second pandemic 
wave. To assess the situation, we conducted a 
hospital-based study on the patients who reported 
with ILI in two different cities located in southern 
provinces of China during December 2009 to March 
2010. The study period covered the second pandemic 
wave in the winter season of 2009 as well as the 
spring festival of 2010, when a large proportion of 
the population travels inside the country.  
 
Methodology 
Patients and inclusion criteria 
A hospital-based study was conducted from 
December 2009 through March 2010 in Shantou and 
Nanchang, two highly populated cities of Guangdong 
and Jiangxi provinces respectively, located in the 
south of China. Following examination by 
physicians, a total of 172 patients who met the 
clinical definition of ILI (presence of two or more 
upper respiratory tract symptoms with/without fever) 
as defined by the United States Centers for Disease 
Control and Prevention (CDC)  [14], were included 
in the study. Two nasopharyngeal (NP) swabs were 
collected in viral transport medium from each patient 
and immediately transported to the laboratory. 
Further clinical and demographic details including 
age, sex, height, weight, history of infection, travel 
and antiviral treatment, co-morbidities, and clinical 
signs were obtained by clinical examination and 
direct interviews. Hospitalized cases remained under 
observation for disease progression, complications, 
treatment outcome, and case mortality, if any.  
Complications that developed in hospitalized cases 
included pneumonia, shortness of breath, acute 
respiratory distress (ARD), sinus tachycardia, pleural 
effusion and respiratory failure. Pneumonia was 
defined as the presence of increased alveolar marking 
observed by chest X ray.  
The study was approved by the ethical board of 
Infectious Disease Hospital, Nanchang University, 
Nanchang 9th Hospital, China. Written consents were 
obtained from all participants involved in the study. 
 
Virus isolation 
 Presence of pH1N1 virus was also evaluated by 
virus isolation. Samples were inoculated in 9- to 11-
day-old embryonated eggs as described previously 
[16] with the exception of incubation at 33oC for 48 
hours. Samples with hemagglutination titer > 1:2 
were considered positive, which was further 
confirmed by real-time RT-PCR for pH1N1 virus 
according to World Health Organization (WHO) and 
US CDC protocols [15]. Egg Infectious Dose50 
(EID50) of positive samples was further determined 
by standard method for future virological studies 
[16]. 
 
Molecular diagnosis and virus typing 
Molecular diagnostic procedures were performed 
according to WHO and US CDC protocols [15]. 
Briefly, RNA was extracted from NP swabs and  
 


















subjected to real-time RT-PCR for the detection of 
pH1N1 virus using a commercial kit (Liferiver, 
Shanghai, China). 
Real-time RT-PCR assays were also developed to 
detect contemporary flu strains including Influenza 
A- H3N2, H1N1 (A/Brisbane/59/2009 lineage, the 
then seasonal strain) and Influenza B. For this 
purpose, RNA samples were reverse transcribed by 
using a high-capacity cDNA RT kit (Applied 
Biosystems, Foster City, USA) followed by 
amplification in a MyCycler PCR machine (BioRad, 
Shanghai, China) using SYBR Green master mix 
(Invitrogen, Guangzhou, China) and 0.5pmol/μl of 
forward and reverse primers as listed in Table 1. 
Positive and negative controls were processed with 
each run. Amplification of human β-actin gene 
served as housekeeping control. 
 
Sequencing 
A total of 10 pH1N1+ samples were selected for 
the sequencing of hemeagglutinin (HA) and 
neuraminidase (NA) genes. Four primer pairs 
covering 400 to 500 bp length with 100bp 
overlapping sequence were designed for each gene. 
RNA were reverse transcribed and subjected to PCR 
amplifications in a final volume of 180µl. Purified 
PCR preps (Promega, Madison, USA) were 
sequenced from Invitrogen (Guanzhou, China). 
Sequences were aligned and assessed by NCBI 
nBLAST and ClustalW multiple alignment tools. 
Phylograms were constructed by MEGA version 4 
using the neighbor joining (NJ) method in the 
nucleotide model of Kimura two-parameters, with 



















at amino acid and nucleotide levels were assessed by 
pairwise p-distances.  
 
Statistics  
Statistical analyses were performed using PSAW 
Statistics 18 (SPSS Inc., Chicago, IL, USA). Fisher’s 
exact and Chi square tests were used for comparison 
of categorical data, and the two-tailed t-test was 
applied in case of continuous variables. Relative risks 
and odds ratios (OR) were estimated with 95% 
confidence intervals (CI) by multivariate analysis.  
 
Results 
Characterization of influenza activity   
From December 2009 to March 2010, NP swabs 
were collected from 172 patients (116 from Shantou 
and 56 from Nanchang) who reported with ILI 
symptoms. Of these, 165 were included in the study 
on the basis of complete clinical information and 
sample quality. The pandemic 2009 H1N1 virus was 
present in 82 (50%) out of 165 ILI cases with the co-
circulation of seasonal strains as follows: influenza A 
H1N1 (A/Brisbane/59/2007-lineage), 4 cases (2%); A 
(H3N2), 1 case (0.6%); type B influenza, 2 cases 
(1%); and unsubtyped influenza A, 26 cases (16%).  
Laboratory investigation revealed that influenza 
activity occurred in three different temporal patterns 
during this period.  As shown in Figure 1, pH1N1 
cases peaked during the first five weeks with a 55% 
(43%-73%) detection rate per week followed by an 
ebb of 22% in February 2010. In the last two weeks 
of March 2010, although ILI cases were fewer, the 
virus resumed a positivity rate of 55%. The median 
age of pH1N1 infected cases was 21 ± 13.8 years  
 
Primer pair Sequences Product size 
MP-FluA F -5′_ AAGACCAATCCTGTCACCTCTGA 3′ 94 
R- 5′_ CAAAGCGTCTACGCTGCAGTCC_3′  
HA-H1$ F-5′_GTAAAACGACGGCCAGTTATAAACAGCAGTCTTC_3′ 444 
R-
5′_GGAAACAGCTATGACCATGATATGTCCAAATGTCTA_3′ 










F-5′-ATG GGT CAG AAG GAT TCC TAT GTG-3′ 359 
R- 5′-CTT CAT GAG GTA GTC AGT CAG GTC-3′ 
Table 1. List of primers used for Influenza virus typing 
$ HA of A/Brisbane/59/2007 like virus 




with a male:female ratio of 1:1.2; however, 55% 
were between the ages of 13 and 30 years. There was 
no difference in the positivity rate of samples 
collected from Shantou and Nanchang, but the 
respective mean age, 18.37 and 27 years, differed 
significantly (P < 0.05).  A total of 14 (17%) of the 
pH1N1 infected cases were children under the age of 
12 years. Patients younger than 30 years of age were 
more likely to be infected with pH1N1 virus than 
those over 30 years, with an odds ratio (OR) of 1.556 
(0.27-1.56 95% CI) (Figure 1). The observation 
confirmed the sustained influenza activity in the 
region with the predominance of pH1N1 throughout 
the study period. It also indicated that, as expected, 
young healthy people were the primary population 
affected during the second pandemic wave. 
 
Clinical picture 
Relative comparison between pH1N1 infected 
and uninfected patients showed that cough (63% vs 
55%, P < 0.05), nasal discharge (44% vs 31%, P 
<0.001) and myalgia (27% vs 22%, P < 0.05) were 
more frequently associated with pH1N1 infection 
(Table 2). Other less frequently observed symptoms 
included fatigue, expectoration, chest pain, 




case of diarrhea or vomiting was seen. It is also 
observed that a considerable number (24%, n = 40) of 
ILI cases were afebrile at the time of sample 
collection while 66% (n = 110) had fever. 
Temperature records were missing for 15 cases.  
Among pH1N1 infected patients, 62 (76%) were 
febrile and 14 (17%) were afebrile (Table 2). No 
significant difference in average temperature was 
found between pH1N1 infected and uninfected 
patients (P = 0.9287). To determine the difference 
between febrile and afebrile patients, we further 
examined the viral replication in nasopharyngeal 
(NP) swabs. Not surprisingly, median viral loads 
were significantly higher in febrile compared with 
afebrile patients (P<0.05) as shown in Figure 2.  
Further analysis revealed that samples from 11 febrile 
cases that were collected between 7 and 12 days post-
onset of illness had detectable pH1N1 RNA levels, 
while none of the samples from afebrile patients was 
found positive with pH1N1 if sampling was late with 
the course of illness. Age specific characterization 
showed that the former group mainly consisted of 
children younger than 12 years of age. To 
summarize, febrile and afebrile pH1N1 infected cases 




H1N1 confirmed cases  
(n = 82) 
Other ILI cases  
(n = 83) 
  






Fever 62 76 48 58 
 
Cough 52 63 46 55 
 
Nasal discharge 36 44 26 31 
 
Myalgia  22 27 18 22 
 
Fatigue 20 24 17 20 
 
Headache 14 17 30 36 
 
Conjunctivitis 9 11 6 7 
 
Expectoration 5 6 0 0 
 
Chest pain 2 2 0 0 
 
Dyspnea 2 2 0 0 
 
Diarrhea 0 0 1 1 
Hospitalization 
 






Pregnancy 3 4 2 2 
 






Pneumonia with other 
complications 
21 26 25 30 
Deaths 
 
0 0 0 0 
Antiviral treatment 
 
9 11 0 0 
Table 2. Clinical information of patients infected with 2009 pandemic H1N1 influenza virus  




Figure 1. Demographic description of ILI cases and pH1N1 infected cases 
(a): Weekly distribution of pH1N1 and other seasonal influenza viruses in ILI cases included in this study (n = 165). Age distribution of ILI 
and pH1N1 infected patients in (b) Shantou (c) Nanchang. (d) Univariate analysis correlates likelihood of pH1N1 infection in different age 
groups. 
Figure 2. Analysis of viral replication 
(a) Scatter plot shows comparison between the viral loads of febrile and afebrile patients. Results are expressed as median mRNA levels with 
interquartile range. Mann Whitney U two-tailed t test was applied to analyze the groups and F test compares variances in each group. (b) 
Evaluation of viral loads between different age groups was analyzed according to day post-onset of illness. Linear regression was applied for 
curve analyses. 



























viral replication actively contributed to the clinical 
course of infection.  
 
Disease progression in pH1N1 infected patients 
We also noticed increased hospitalization rates 
among patients with laboratory-confirmed pH1N1 
infection. Out of 82 patients, 32 (39%) pH1N1 
infected cases were hospitalized because of the 
development of intense respiratory tract symptoms 
while 12 (15%) such patients refused to be 
hospitalized. Out of 32 hospitalized cases, 21 
developed pneumonia while other severe 
complications such as shortness of breath, acute 
respiratory distress (ARD), sinus tachycardia, pleural 
effusion and respiratory failure were observed in a 
few cases. According to multivariate analysis, 
patients with underlying co-morbidities were more 
prone to develop complications. In addition, 
complications were less likely to occur among those 
patients who were less than 40 years of age and those 
who were treated with antiviral drugs (Figure 3). The 
inverse correlation of antiviral treatment and age with 
the development of complications was perhaps due to 




























cases. Median viral loads of hospitalized cases were 
not significantly different from non-hospitalized and 
non-complicated cases. Antiviral treatment with 
oseltamivir was given to 9 (28%) of the hospitalized 
cases. There were no cases with fatalities in this 
study.  
 
Genetic characterization of HA gene 
HA genes of 10 pH1N1 strains were sequenced. 
BLAST analysis based on the number of nucleotides 
present in HA gene exhibited 99% identity with the 
prototypic A/California/07/2009 H1N1 strain. It also 
indicated a close identity ( > 99%) with 
A/Nanjing/3/2009 and other Chinese isolates, 
indicating the spread of homogenous strains in China.  
Multiple alignments revealed several nucleotide 
substitutions in our strains as shown in Figure 4. 
Several mutations such as E391K, P100S, I208L, 
T214A, S220T and I338V were also present in our 
strains as they were in other representative global 
isolates. Our samples also contained unique 
mutations such as A409V, D144E, K71N, S340F and 
H416P; however, no correlation with respect to 
demography, disease progression, and clinical 
findings was found (Table 3).  
Figure 3. Multivariate analysis illustrating factors increasing the risk of complication development in pH1N1 cases.  
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  Figure 4. Genetic characterization of 2009 pandemic H1N1 influenza 
Sequences of (a) HA and (b) NA genes were aligned with prototype pH1N1 influenza strains using ClustalW multiple alignment tools. 
Nucleotide substitutions are marked as grey, (c) Phylogenetic analysis of HA gene with other representative isolates from China 
(unlabelled) and United States by neighbor joining method. Bookstrap values represent 1000 replicates.   






























































































































































































Age (yrs) 32 21 19 6 25 20 8 21 21 NA 
Gender F M F M M F M F M NA 
Temp. (oC) 39.1 38.5 39.2 38.8 37 39.1 38.5 37 37 37 
Hospitalization           
Complication           
Pregnancy/ Co-
morbidities 






























































































          
P100S           
D144E           
S145P           
I208L           
T214A           
S220T           
I338V           
S340F           
E391K           
A409V           






























































































N42S           
V106I           
N248D           
mutations are compared with prototypic strain: A/California/07/2009 H1N1, NA – not available, ND – Not done 
Table 3.  Mutation analysis of selected strains of pH1N1 influenza virus 
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To analyze the pattern of the pandemic in two 
different pandemic waves in China, we performed 
HA based phylogenetic analysis of pH1N1 strains 
with other Chinese isolates that are available on the 
NCBI influenza database. In addition, HA-pH1 
sequences of Chinese strains which were isolated 
during: 1) first pandemic wave (from March to 
August 2009,n = 29); 2) second pandemic wave 
(from September 2009 to March 2010, n = 49) were 
compared with HA-pH1 sequences reported from the 
United States of America (USA) during the same 
time periods: 1) first pandemic wave (March to 
August 2009, n = 347); and 2) second pandemic 
wave (September 2009 to March 2010, n = 336). 
Sequences were randomly selected from the NCBI 
influenza resource database. Phylogenetic analysis 
revealed that dominant homogenous strains in China 
were closely related to the prototypic global strains 
A/California/04/2009 and A/California/07/2009 
irrespective of flu season (Figure 4). The results also 
indicated the minor epidemiological differences 
between pH1N1 strains that circulated in China and 
the USA during the second pandemic wave. 
 
Genetic characterization of NA gene 
Sequence analysis of the NA gene exhibited 
several mutations in the nucleotide sequence leading 
to amino acid substitutions N248D and V106I, which 
previously have been identified in other Chinese 
isolates including A/Nanjing/3/2009 and 
A/Shanghai/1/2009. No H274Y substitution targeting 
oseltamivir resistance was observed. An additional 
substitution of Asparagine to Serine at residue 42 was 
found in one strain (Figure 4). 
 
Discussion 
In this study, the sample collection took place 
from December 2009 to March 2010, thereby 
covering the second pandemic wave that occurred 
during the winter of 2009-2010 in the northern 
hemisphere. Interestingly, the initial wave of 
influenza activity faded and it was followed by a 
modest resurgence of the disease, which may have 
been caused by the large movement of people that 
takes place during the Chinese Spring Festival. 
During the previous influenza seasons, severe 
respiratory complications were more prevalent 
among the elderly; however, a shift in the age 
distribution towards younger patients has previously 
been observed in the 2009 influenza pandemic, 
although the reasons for this phenomenon remain 
unclear. In our study the median age was 21 years, 
which is comparable to those of other studies done in 
China that reported median ages of  24  years [7] and 
21 years [17] and also studies in North America with 
20 years [18],  Spain with 29 years [19] and Russia 
with 18 years [20].  We found that during the 
pandemic period 17% of overall pH1N1 infected 
cases were children ( < 12 years). This observation 
agrees with the published data from China and 
neighboring countries [7,21] but is in contrast with 
that of North America where pediatric infections 
were more prevalent [22,23].  
Our results confirm previous reports indicating 
that young and middle-aged individuals infected with 
pH1N1 are more prone to develop severe 
complications, as opposed to patients with seasonal 
influenza where the elderly was the most affected 
group [9,24]. In the areas of southern China covered 
in this study, human Infection with pH1N1 virus 
culminated in 50% of ILI cases with higher rates of 
hospitalization (39%) and recovery (100%) compared 
with other cohorts from the United States, Mexico, 
Canada, and Beijing [3,10,25,26], illustrating a 
slightly different trend of pandemic infection in this 
region.  
High fever is often associated with increased 
viral loads and prolonged shedding that provides an 
extended opportunity for disease establishment; 
therefore, it is often considered a key determinant of 
disease severity. In our studied population, clinical 
(febrile) and subclinical (afebrile) cases were 
simultaneously present with efficient viral replication 
in the former group as reported elsewhere [27]. 
Interestingly, unlike other reports, we observed a 
higher rate of subclinical infection [7,17,28] that 
probably contributed toward the overall low mortality 
rate and may have acted as a silent source of 
infection in the community. One possible reason for 
the difference in observations is population 
characteristic because south China is dominated by 
the Han ethnic group so it may be possible that host 
factor contributes towards the susceptibility and 
clinical course of disease.  
Genetic analysis indicated the presence of several 
mutations in NA and HA genes including HA- 
E391K, P100S, T214A, 1338V, I208L, S220T and 
NA- N248D, V106I, which have already been 
observed in various strains globally [29,30]. 
Phylogenetic analysis of HA sequences reported by 
us and other Chinese labs showed that, during first 
pandemic wave, H1N1 virus was predominantly 
homogenous with prototypic strains with some minor 
mutations, unlike reports from the USA which 
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showed distinct heterogeneities at that time [31]. 
Thus we speculate that in the second pandemic wave 
from September 2009 onward, China and the United 
States might have experienced different patterns of 
viral circulation. However, this observation is based 
only on HA gene sequences available in the NCBI 
influenza resource database. Genome-wide analysis 
is necessary to draw final conclusions.  
This study provides the description of pandemic 
influenza activity in southern parts of China showing 
the sustained pH1N1 infection, less frequent pediatric 
infection, simultaneous presence of febrile and 
afebrile cases, as well as higher rate of hospitalization 
and recovery as unique features that contribute 
valuable information to the current understanding of 
the 2009 influenza pandemic.  
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